Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

HLA-DR Antikörper

HLA-DR Reaktivität: Human FACS, WB, IP Wirt: Maus Monoclonal MEM-12 unconjugated
Produktnummer ABIN238445
  • Target Alle HLA-DR Produkte
    HLA-DR
    Reaktivität
    • 140
    • 22
    • 21
    • 20
    • 20
    • 14
    • 11
    • 8
    • 5
    • 4
    • 3
    • 3
    • 2
    • 1
    Human
    Wirt
    • 121
    • 13
    • 10
    Maus
    Klonalität
    • 137
    • 6
    Monoklonal
    Konjugat
    • 48
    • 16
    • 16
    • 11
    • 10
    • 5
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser HLA-DR Antikörper ist unkonjugiert
    Applikation
    • 123
    • 35
    • 26
    • 24
    • 17
    • 13
    • 12
    • 10
    • 7
    • 6
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Flow Cytometry (FACS), Western Blotting (WB), Immunoprecipitation (IP)
    Kreuzreaktivität (Details)
    Species reactivity (tested):Human
    Produktmerkmale
    Synonyms: HLA-DR, HLA class II histocompatibility antigen DR, MHC class II antigen DR
    Aufreinigung
    Affinity Chromatography on Protein A
    Immunogen
    Thymocyte membrane
    Klon
    MEM-12
    Isotyp
    IgG1
  • Applikationshinweise
    Flow Cytometry: Positive Control: B-lymphocytes, Monocytes, DAUDI cell line, RAJI cell line. Immunoprecipitation: Positive control: B-lymphocytes, Monocytes, DAUDI cell line, RAJI cell line. Western Blotting (Non-Reducing Conditions): Positive control: B-lymphocytes, Monocytes, DAUDI cell line, RAJI cell line. Sample preparation: Resuspend approx.50 mil. cells in 1 mLcold Lysis buffer (1 % laurylmaltoside in 20 mM Tris/Cl, 100 mM NaCl pH 8.2, 50 mM NaF including Proteaseinhibitor Cocktail). Incubate 60 min on ice. Centrifuge to remove cell debris. Mix lysatewith non-reducing SDS-PAGE sample buffer. Do not heat/boil.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1.0 mg/mL
    Buffer
    PBS, pH 7.4 with 15 mM sodium azide as preservative
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer. Avoid repeated freezing and thawing.
    Shelf life: one year from despatch.
    Haltbarkeit
    12 months
  • Target
    HLA-DR
    Andere Bezeichnung
    HLA Class II DR (HLA-DR Produkte)
    Hintergrund
    HLA DR, like other MHC class II molecules, is a transmembrane glycoprotein composed of an alpha chain (36 kDa) and a beta chain (27 kDa). It is expressed primarily on antigen presenting cells such as B lymphocytes, monocytes, macrophages, thymic epithelial cells and activated T lymphocytes. Three loci, DR, DQ and DP, encode the major expressed products of the human class II region. The human MHC class II molecules bind intracellularly processed peptides and present them to T helper cells. They therefore have a critical role in the initiation of the immune response.Synonyms: HLA class II histocompatibility antigen DR, HLA-DR, MHC class II antigen DR
    Pathways
    Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Sie sind hier:
Kundenservice